Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.
Molnupiravir reduces severe illness and death, but it must be started within days after developing symptoms.
People under 50 who were cured of hepatitis C were at comparable risk to the general population.
Assessing patient-reported outcomes can support treatment for hard-to-reach populations.
The risk was lower in people who had achieved a sustained virological response compared with those who had not.
One link between coronaviruses (COVID-19) and the HIV drug Kaletra dates back to the 2003 outbreak of SARS.
Herpes simplex virus 1 (HSV1) may account for half of Alzheimer’s cases, according to a review of three recent studies.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.